Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer

A promising option as the treatment of choice for premenopausal patients with locally advanced or metastatic breast cancer (MBC) could be the combination of a luteinizing hormone-releasing hormone analog and an aromatase inhibitor. However, no prospective studies on the efficacy of goserelin with ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiayu, Xu, Binghe, Yuan, Peng, Ma, Fei, Li, Qing, Zhang, Pin, Cai, Ruigang, Fan, Ying, Luo, Yang, Li, Qiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504532/
https://www.ncbi.nlm.nih.gov/pubmed/26131799
http://dx.doi.org/10.1097/MD.0000000000001006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504532/
https://www.ncbi.nlm.nih.gov/pubmed/26131799
http://dx.doi.org/10.1097/MD.0000000000001006

Ejemplares similares